Work

Venetoclax Has Modest Efficacy in the Treatment of Patients with Relapsed T-Cell Prolymphocytic Leukemia

Year: 2020

Type: article

Source: Blood

DOI: 10.1182/blood-2020-134586

Authors: Paul J. Hampel, Sameer A. Parikh, Timothy G. Call, Mithun Vinod Shah, Nabila Bennani, Aref Al-Kali, Kari G Rabe, Yucai Wang, Eli Muchtar, Jose F. Leis, Saad S. Kenderian, Amber B. Koehler, Susan M. Schwager, Daniel L. Van Dyke, Susan L. Slager, Neil E. Kay, Min Shi, Wei Ding

Institution: Mayo Clinic

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3096739569

FWCI: 0.11

Cites:

Cited by: 1

Related to: 10